Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1290
| Despition | Insulin Receptor Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1348 | Presenilin 1 Blocking Peptide (AC1348) | 250 µg | inquiry |
| ACPP-1507 | Human SDC4 Protein (AC1507) | 2 µg | inquiry |
| ACPP-1052 | Recombinant Human PGRPS Protein (Fc Tag) (AC1052) | 50 µg | inquiry |
| ACPP-1093 | Synthetic Nanodisc Human CCR5 Protein (AC1093) | 10 µg | inquiry |
| ACPP-1226 | PDE7A Blocking Peptide (AC1226) | 250 µg | inquiry |
| ACPP-1601 | Rat ACRP30 Protein (AC1601) | 2 µg | inquiry |
| ACPP-1150 | Synthetic Nanodisc Human TRPV1 Protein (AC1150) | 10 µg | inquiry |
| ACPP-1095 | Synthetic Nanodisc Human MLC1 Protein (AC1095) | 10 µg | inquiry |
| ACPP-1762 | Human SNAP25 Protein, His (AC1762) | 10 µg | inquiry |
| ACPP-1278 | EAAT1 Blocking Peptide (AC1278) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.